This program is designed to provide decision-makers, policymakers and professional working in policy with a foundational understanding of AI technology.
We use cookies to analyze the browsing and usage of our website and to personalize your experience. You can disable these technologies at any time, but this may limit certain functionalities of the site. Read our Privacy Policy for more information.
Setting cookies
You can enable and disable the types of cookies you wish to accept. However certain choices you make could affect the services offered on our sites (e.g. suggestions, personalised ads, etc.).
Essential cookies
These cookies are necessary for the operation of the site and cannot be deactivated. (Still active)
Analytics cookies
Do you accept the use of cookies to measure the audience of our sites?
Multimedia Player
Do you accept the use of cookies to display and allow you to watch the video content hosted by our partners (YouTube, etc.)?
The aftermath of the Covid-19 pandemic saw more severe outcomes for racial minority groups and economically-deprived communities. Such dispa… (see more)rities can be explained by several factors, including unequal access to healthcare, as well as the inability of low income groups to reduce their mobility due to work or social obligations. Moreover, senior citizens were found to be more susceptible to severe symptoms, largely due to age-related health reasons. Adapting vaccine distribution strategies to consider a range of demographics is therefore essential to address these disparities. In this study, we propose a novel approach that utilizes influence maximization (IM) on mobility networks to develop vaccination strategies which incorporate demographic fairness. By considering factors such as race, social status, age, and associated risk factors, we aim to optimize vaccine distribution to achieve various fairness definitions for one or more protected attributes at a time. Through extensive experiments conducted on Covid-19 spread in three major metropolitan areas across the United States, we demonstrate the effectiveness of our proposed approach in reducing disease transmission and promoting fairness in vaccination distribution.
2024-03-24
Proceedings of the AAAI Conference on Artificial Intelligence (published)